Objectives & CME
The American Society for Reproductive Immunology (ASRI) was founded to foster the field of Reproductive Immunology so both clinicians and basic researchers could better understand the immune-based etiologies underlying reproductive anomalies. The annual ASRI meetings are designed to acquaint attendees with new questions and new techniques underlying the normal and abnormal events at the maternal-fetal interface. It is increasingly clear that the immunity, placenta and hormones play a pivotal role in orchestrating in utero embryonic development. There appears to be a composite triad of dynamic equilibrium involving the placental milieu, the fetus and the mother. Thus, the maternal-fetal interface can provide a blueprint for the events that lead to a normal or a compromised pregnancy. Recent revolutionary advances in technical know-how and thematic excellence now make it possible to not only investigate the issues in animals but to transport this knowledge from bench to bedside. The Clinical Symposium and the 36th Annual meeting will focus on recent state of the art techniques and themes. Each topic will be lectured by an expert in the respective field. At the end of the meeting, all participants should be able to:
• Evaluate epigenetics and exosomes in placenta and their clinical relationship
• Apply recent state-of-the art techniques and themes in obstetrics
• Explain the role of inflammatory immune responses in obstetrical complications such as pre-eclampsia and preterm labor.
• Evaluate the neurological control of inflammatory immune response
• Assess the consequences of Zika virus pandemic on pregnancy outcome.
• Assess whether we are winning the war against HIV
• Understand the interplay between hormones, mucosal immunity, semen factors, and susceptibility to HIV
• Understand the role of microbiome in adverse pregnancy outcomes
• Assess progress in vaccines for STIs
• Evaluate specialized immunity in male and female reproduction
• Debate mouse to human continuum in reproduction
This conference has been approved for 18.0 CME hours by the accrediting institution, the Chicago Medical School at Rosalind Franklin University of Medicine and Science.